Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Capital Reinvestment Ratio
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Capital Reinvestment Ratio of 2.24x as of December 2024, meaning it reinvests 2% of its operating cash flow (CN¥47.07 Million) in capital expenditures (CN¥105.31 Million). Check 301258 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Suzhou Fushilai Pharmaceutical Co. Ltd. Capital Reinvestment Ratio (2019–2024)
This chart tracks Suzhou Fushilai Pharmaceutical Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods. For the full cash flow conversion analysis, see 301258 cash generation efficiency.
Annual Capital Reinvestment Ratio for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year Capital Reinvestment Ratio for Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. See how much free cash does Suzhou Fushilai Pharmaceutical Co. Ltd. generate to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.24x | CN¥47.07 Million | CN¥105.31 Million | ▲ +409.4% |
| 2023 | 0.44x | CN¥94.77 Million | CN¥41.62 Million | ▲ +32.5% |
| 2022 | 0.33x | CN¥151.19 Million | CN¥50.11 Million | ▼ -18.0% |
| 2021 | 0.40x | CN¥199.73 Million | CN¥80.75 Million | ▲ +2.7% |
| 2020 | 0.39x | CN¥166.85 Million | CN¥65.69 Million | ▼ -16.4% |
| 2019 | 0.47x | CN¥150.55 Million | CN¥70.93 Million | — |